Study details
Enrolling now
1726-nm Laser for Acne Inversa (Hidradenitis Suppurativa)
Wynn Medical Center
NCT IDNCT07155239ClinicalTrials.gov data as of Apr 2026
Phase
Phase 1
Target enrollment
30
Study length
about 1.3 years
Ages
18–60
Locations
1 site in CA
About this study
This trial is testing whether a 1726-nm diode laser can safely reduce inflammatory HS lesions in Hurley stage I-II disease. Adults with bilateral affected areas will be randomized to receive active laser treatment or a sham procedure. Participants will have three treatment sessions over 8 weeks and follow-up through Week 24 while continuing their stable HS medications.
Based on ClinicalTrials.gov records.
What participants do
- 1.Use AviClear Lase Treatment
- 2.Use Sham (No Treatment)
PhasePhase 1
Primary goalChange in pain
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low8%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Endpoints
Primary: Change in pain
Secondary: Change in depression scale